top of page

About
- Our Company
- Our Leadership Team
Science
Products
Pipeline
Newsroom
Contact
Investors
More

Use tab to navigate through the menu items.

Newsroom

All Posts
Publication
News

YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market

Aug 30, 2025

Breeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma Limited

Breeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma Limited

Breeze Holdings Acquisition Corp. Announces Definitive Agreement to Merge with YD Biopharma Limited

Sep 25, 2024

3D Global Biotech and YD Biopharma Forge Strategic Partnership to Drive Biotech Innovation

3D Global Biotech and YD Biopharma Forge Strategic Partnership to Drive Biotech Innovation

3D Global Biotech and YD Biopharma Forge Strategic Partnership to Drive Biotech Innovation

Jun 19, 2024

DNA Methylation

Investor Relations

Laboratory Developed Tests Services

Exosome Based Therapies

Clinical Trial Drug Distribution

Health Supplements

Privacy Statement

Data Rights Form

21720 23rd Dr. SE, Suite 275,

Bothell, WA 98021, USA

Email: info@ydesgroup.com

Tel: +1 (206) 888-0858

bottom of page